Evidence map›Paper›PMID 42182661›Full record

ArticleJournal of thoracic disease2026

Hou-Mei Xiang, Yi Wang, You Xu, Jia-Yan Sun, Qiang Guo

Abstract read
In one paragraph

Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hou-Mei Xiang *Medical College of Soochow University, Suzhou, China.
Yi Wang *Medical College of Soochow University, Suzhou, China.
You XuMedical College of Soochow University, Suzhou, China.
Jia-Yan SunMedical College of Soochow University, Suzhou, China.
Qiang GuoMedical College of Soochow University, Suzhou, China.ORCID https://orcid.org/0000-0002-2326-2244

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pulmonary arterial hypertension (PAH) is a life-threatening and cardiovascular disease characterized by elevated pulmonary artery pressure leading to right ventricular hypertrophy. Its features include endothelial dysfunction and vascular remodeling. Inflammation is a key factor in PAH progression. This study focuses on the role and mechanism of sine oculis homeobox 1 ( Methods: To analyze the transcriptomic data from mouse lung tissues (control Results: Through linear regression analysis in the transcriptome sequencing data, we found that Conclusions: We conclude

Indexed as

Endothelial dysfunctioninterleukin-6 (IL-6)pulmonary hypertensionsine oculis homeobox 1 (SIX1)STAT3

Identifiers

PMID42182661
PMCPMC13190016

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.